This pullback appears to be profit-taking after a volatile week that saw gains of roughly 30% from the Oramed deal. The extremely light volume (0.2x normal) suggests this is not institutional selling but rather thin trading and natural consolidation. The pattern of sharp gains followed by modest retracements has repeated multiple times this week.
This is a permanent link to this specific analysis (ID: 2234)
Back to Dashboard